FLORA ELISABETH VAN LEEUWEN

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. pmc Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
    M Schaapveld
    Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Br J Cancer 107:1637-43. 2012
  2. pmc Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)
    Anouk Pijpe
    Netherlands Cancer Institute, Department of Epidemiology and Biostatistics, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands
    BMJ 345:e5660. 2012
  3. pmc A trial of consent procedures for future research with clinically derived biological samples
    E Vermeulen
    The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
    Br J Cancer 101:1505-12. 2009
  4. pmc Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries
    Michael E Jones
    Section of Epidemiology, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK
    Breast Cancer Res 14:R91. 2012
  5. pmc A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges
    Annelies Overbeek
    Department of Paediatrics, Division of Paediatric Oncology Haematology, VU University Medical Center, PO Box 7057, Amsterdam, 1007MB, The Netherlands
    BMC Cancer 12:363. 2012
  6. pmc Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
    F E van Leeuwen
    Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Hum Reprod 26:3456-65. 2011
  7. pmc Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients
    Marjanka K Schmidt
    Departments of Epidemiology, Experimental Therapy and Pathology, Netherlands Cancer Institute, The Netherlands
    Breast Cancer Res 11:R89. 2009
  8. pmc Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study
    Annegien Broeks
    Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Breast Cancer Res 9:R26. 2007
  9. pmc Incidence of cancer in the area around Amsterdam Airport Schiphol in 1988-2003: a population-based ecological study
    Otto Visser
    Comprehensive Cancer Centre Amsterdam, PO Box 9236, 1006 AE Amsterdam, The Netherlands
    BMC Public Health 5:127. 2005
  10. ncbi request reprint Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease
    Flora E van Leeuwen
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Natl Cancer Inst 95:971-80. 2003

Collaborators

  • Lois B Travis
  • V J Verwaal
  • W J Louwman
  • R de Wit
  • J A Gietema
  • J A Witjes
  • Annegien Broeks
  • C B Lambalk
  • H Klip
  • M Schaapveld
  • Nicola S Russell
  • Berthe M P Aleman
  • Marilyn Stovall
  • Evert M Noordijk
  • Mary K Gospodarowicz
  • Annelies Overbeek
  • Michael E Jones
  • Anouk Pijpe
  • Douglas F Easton
  • Marjanka K Schmidt
  • E Vermeulen
  • Otto Visser
  • Hanne Meijers-Heijboer
  • Christi J van Asperen
  • Ausrele Kesminiene
  • Matti A Rookus
  • Eline van Dulmen-den Broeder
  • Nadine Andrieu
  • Susan Peock
  • Dorine Bresters
  • Jean Pierre Fricker
  • Hester van Boven
  • Michael F Press
  • Joan Paterson
  • Birgitta Versluys
  • Wilhelmina E Hoogendoorn
  • Marian Je Mourits
  • Leslie Bernstein
  • Michael Hauptmann
  • D Gareth Evans
  • Marleen H van den Berg
  • Peggy Manders
  • Leontien C M Kremer
  • Anthony J Swerdlow
  • David Goldgar
  • Isabelle Thierry-Chef
  • Gertjan J L Kaspers
  • Debra Frost
  • Margreet G E M Ausems
  • Rosalind A Eeles
  • Jacqueline J Loonen
  • Elisabeth Cardis
  • Harry Hollema
  • Wim J E Tissing
  • Christine Lasset
  • Catherine Nogues
  • Marion Gauthier-Villars
  • Marry M van den Heuvel-Eibrink
  • H van der Poel
  • Johanna Tommiska
  • Carl Blomqvist
  • S Horenblas
  • A Cats
  • Heli Nevanlinna
  • Manjeet Humphreys
  • Scarlett A Reincke
  • M Kuenen
  • M J Baas-Vrancken Peeters
  • M K Schmidt
  • N K Aaronson
  • Rainer Fagerholm
  • H Boot
  • Laura J Van't Veer
  • Paul D P Pharoah
  • Mitul Shah
  • Thilo Dork
  • Joop H van Wijnen

Detail Information

Publications10

  1. pmc Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
    M Schaapveld
    Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Br J Cancer 107:1637-43. 2012
    ..Testicular germ cell tumour (TGCT) patients are at increased risk of developing a contralateral testicular germ cell tumour (CTGCT). It is unclear whether TGCT treatment affects CTGCT risk...
  2. pmc Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)
    Anouk Pijpe
    Netherlands Cancer Institute, Department of Epidemiology and Biostatistics, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands
    BMJ 345:e5660. 2012
    ..To estimate the risk of breast cancer associated with diagnostic radiation in carriers of BRCA1/2 mutations...
  3. pmc A trial of consent procedures for future research with clinically derived biological samples
    E Vermeulen
    The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
    Br J Cancer 101:1505-12. 2009
    ..The aims of this study were to determine which consent procedure patients prefer for use of stored tissue for research purposes and what the effects of consent procedures on actual consenting behaviour are...
  4. pmc Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries
    Michael E Jones
    Section of Epidemiology, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK
    Breast Cancer Res 14:R91. 2012
    ..We investigated whether tamoxifen therapy increases mortality among breast cancer patients subsequently diagnosed with endometrial cancer...
  5. pmc A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges
    Annelies Overbeek
    Department of Paediatrics, Division of Paediatric Oncology Haematology, VU University Medical Center, PO Box 7057, Amsterdam, 1007MB, The Netherlands
    BMC Cancer 12:363. 2012
    ....
  6. pmc Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
    F E van Leeuwen
    Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Hum Reprod 26:3456-65. 2011
    ..Long-term effects of ovarian stimulation for IVF on the risk of ovarian malignancies are unknown...
  7. pmc Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients
    Marjanka K Schmidt
    Departments of Epidemiology, Experimental Therapy and Pathology, Netherlands Cancer Institute, The Netherlands
    Breast Cancer Res 11:R89. 2009
    ..We investigated the effects of the germ-line single nucleotide polymorphisms TP53 R72P (215G>C) and MDM2 SNP309 (-410T>G), and p53 protein expression in breast tumors on survival...
  8. pmc Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study
    Annegien Broeks
    Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Breast Cancer Res 9:R26. 2007
    ..Radiation exposure at a young age is one of the strongest risk factors for breast cancer. Germline mutations in genes involved in the DNA-damage repair pathway (DDRP) may render women more susceptible to radiation-induced breast cancer...
  9. pmc Incidence of cancer in the area around Amsterdam Airport Schiphol in 1988-2003: a population-based ecological study
    Otto Visser
    Comprehensive Cancer Centre Amsterdam, PO Box 9236, 1006 AE Amsterdam, The Netherlands
    BMC Public Health 5:127. 2005
    ..We investigated whether residents of the area around Schiphol are at higher risk of developing cancer than the general Dutch population...
  10. ncbi request reprint Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease
    Flora E van Leeuwen
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Natl Cancer Inst 95:971-80. 2003
    ..Female survivors of Hodgkin's disease (HD) have a strongly elevated risk of breast cancer, but factors responsible for the increased risk are not well known...

Research Grants2

  1. Risk and prognosis of uterine corpus cancer after tamoxifen treatment for breast
    Flora van Leeuwen; Fiscal Year: 2007
    ..Cox regression and conditional logistic regression will be used for the analyses of the final combined datasets. ..